sepsi
lead
caus
death
worldwid
angu
van
der
poll
aris
host
respons
pathogen
infect
bacteri
fungal
viral
parasit
infect
injuri
tissu
organ
hotchkiss
monneret
payen
present
sever
acut
respiratori
syndrom
coronaviru
newli
recogn
virus
spread
rapidli
throughout
wuhan
hubei
provinc
provinc
china
around
world
infect
close
peopl
china
kill
until
feb
specif
effect
drug
cours
sepsi
innat
acquir
immun
system
involv
develop
mononuclear
phagocyt
system
play
crucial
role
although
timelin
immunolog
alter
sepsi
well
understood
suggest
evid
demonstr
develop
sepsi
involv
two
distinct
stage
initi
cytokin
storm
hyperinflamm
subsequ
immunosuppress
hypoinflamm
exist
concomitantli
domin
differ
stage
hotchkiss
monneret
payen
hutchin
unsing
hotchkiss
ayala
uncontrol
cytokin
storm
respons
death
occur
within
first
day
wherea
immunosuppress
predominantli
caus
mortal
later
stage
sepsi
fact
patient
die
first
three
day
sepsi
might
due
increas
suscept
weakli
virul
pathogen
opportunist
bacteria
eg
pseudomona
aeruginosa
indic
failur
host
erad
invad
pathogen
hotchkiss
monneret
payen
skrupki
kerbi
hotchkiss
patient
immunosuppress
stage
less
monocytesmacrophag
produc
cytokin
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
might
relat
disord
immun
respons
sepsi
hotchkiss
monneret
payen
hutchin
unsing
hotchkiss
ayala
demonstr
impair
function
monocytesmacrophag
tightli
relat
decreas
remov
bacteria
consid
drug
base
inhibit
critic
proinflammatori
mediat
fail
therapeut
strategi
improv
immunosuppress
focu
sepsi
treatment
cohen
hotchkiss
monneret
payen
kox
volk
kox
volk
prucha
zazula
russwurm
autophagi
fundament
cellular
process
involv
defens
infect
intracellular
pathogen
casanova
although
contradictori
find
report
ho
et
al
accumul
evid
suggest
autophagi
play
key
role
sepsi
consid
potenti
target
sepsisinduc
immunosuppress
ren
zhang
wu
yao
promis
focu
autophagi
axi
unveil
mechan
sepsisinduc
immunosuppress
discov
novel
immunoregul
therapi
sepsi
artesun
effect
reliabl
antimalari
drug
low
toxic
burrow
chibal
well
clark
white
gaunt
winstanley
ward
possess
sever
interest
effect
antiinflamm
effect
efferth
dunstan
sauerbrey
miyachi
chitambar
li
et
al
miranda
et
al
wang
et
al
previous
show
protect
septic
anim
inhibit
proinflammatori
cytokin
releas
cytokin
storm
stage
li
et
al
suggest
could
exhibit
antiinflammatori
activ
cytokin
storm
phase
sepsi
herein
cecal
ligat
punctur
clp
induc
sepsi
immunosuppress
mice
model
employ
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
investig
effect
sepsisinduc
immunosuppress
lipopolysaccharideendotoxin
lp
toler
cell
model
establish
unveil
underli
mechan
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
method
balbc
mice
sex
half
male
half
femal
weight
g
age
week
obtain
beij
hfk
bioscienc
beij
china
hous
pathogenfre
facil
artifici
lightdark
cycl
third
militari
medic
univers
mice
provid
food
purifi
water
ad
libitum
mice
cage
anim
care
experiment
procedur
conduct
approv
laboratori
anim
welfar
ethic
committe
third
militari
medic
univers
anim
studi
report
complianc
arriv
guidelin
kilkenni
brown
cuthil
emerson
altman
group
recommend
made
british
journal
pharmacolog
murin
macrophagelik
cell
line
cell
human
monocyt
cell
purchas
american
type
cultur
collect
manassa
va
usa
cell
cultur
dulbecco
modifi
eagl
medium
dmem
supplement
lowlp
fetal
bovin
serum
fb
hyclon
logan
ut
usa
penicillinstreptomycin
regular
medium
humid
atmospher
co
cell
cultur
rpmi
hyclon
regular
medium
suspens
deriv
macrophag
obtain
differenti
cell
phorbol
pma
sigmaaldrich
st
loui
mo
usa
treatment
nm
h
accord
previou
studi
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
mous
periton
macrophag
pm
obtain
balbc
mice
mous
intraperiton
inject
ml
thioglycol
sigmaaldrich
day
sacrif
use
isofluran
day
intraperiton
inject
ml
dmem
regular
medium
periton
cell
collect
cell
cultur
dish
two
hour
later
float
cell
remov
wash
cell
phosphatebuff
salin
pb
attach
cell
consid
pm
puriti
subject
experi
primari
mous
macrophag
cell
line
maintain
regular
medium
humidifi
co
atmospher
reagent
utensil
use
experi
lpsfree
pseudomona
aeruginosa
pa
clinic
insol
kindli
provid
prof
peiyuan
xia
southwestern
hospit
chongq
china
singl
coloni
pick
viabl
grow
muellerhinton
mh
agar
plate
transfer
ml
liquid
mh
medium
cultiv
aerob
orbit
shake
incub
h
cultur
transfer
ml
fresh
mh
medium
anoth
h
bacteri
cultur
within
logarithm
phase
growth
measur
smartspec
spectrophotomet
biorad
hercul
ca
usa
suspens
centrifug
g
min
harvest
pellet
wash
twice
pellet
resuspend
steril
normal
salin
bacteria
dilut
steril
normal
salin
achiev
termin
concentr
colonyform
unit
cfu
ml
calcul
accord
bacteri
growth
curv
determin
lab
concentr
od
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
cfuml
current
clp
rodent
regard
gold
standard
sepsi
research
rittirsch
huberlang
flierl
ward
clp
immunosuppress
mice
clp
mice
second
bacteri
infect
model
establish
lab
describ
deng
et
al
briefli
clp
mice
establish
ligat
distal
cm
cecum
punctur
steel
needl
intraven
inject
pa
cfukg
h
clp
surgeri
figur
nation
medicin
standard
ad
attach
sodium
bicarbon
inject
shake
minut
complet
dissolv
dilut
steril
normal
salin
achiev
termin
concentr
mgkg
intramuscularli
inject
h
follow
clp
surgeri
surviv
rate
mice
observ
day
clp
mice
sacrif
h
pa
inject
blood
lung
spleen
tissu
collect
cfu
count
assay
elisa
lp
toler
extens
use
simul
sepsisinduc
immunosuppress
phase
vitro
li
et
al
herein
cell
model
lp
toler
establish
mous
pm
cell
briefli
cell
cultur
lp
sigmaaldrich
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
ngml
h
cultur
supernat
replac
follow
addit
lp
ngml
establish
lpstoler
cell
model
treatment
ad
lp
ngml
lp
ngml
simultan
autophagi
inhibitor
treatment
mm
sigmaaldrich
bafilomycin
baf
ngml
medchemexpress
nj
usa
sigmaaldrich
ad
h
first
lp
ngml
also
treatment
simultan
supernat
cell
collect
h
last
lp
ngml
addit
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
ncoe
shrna
target
mous
vdr
neg
control
shrna
design
synthes
insert
lentiviru
vector
genechem
genechem
corpor
shanghai
china
result
recombin
lentiviru
name
vdrkd
nckd
lentiviru
transfect
cell
cultur
confluenc
transfect
lentiviru
accord
protocol
lentiviru
oper
manual
h
three
day
renew
cultur
regular
dmem
cell
subject
treatment
lentiviru
vdrkd
nckd
dilut
total
volum
contain
tu
balbc
mice
transfect
tail
intraven
inject
report
morizono
et
al
one
week
later
mice
sacrif
spleen
tissu
collect
detect
infect
effici
clp
model
treatment
employ
transfect
mice
tissu
collect
cytokin
western
bolt
assay
interact
molecular
predict
perform
protein
use
weight
ensembl
similar
we
algorithm
zheng
et
al
assembl
tradit
chines
medicin
system
pharmacolog
databas
analysi
platform
tcmsp
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
ru
et
al
we
develop
determin
drug
affili
target
evalu
overal
similar
ensembl
rather
singl
ligand
judgment
allow
us
discoveri
scaffold
hop
ligand
ligand
structur
physicochem
featur
calcul
use
chemic
develop
kit
cdk
steinbeck
han
kuhn
horlach
luttmann
willighagen
dragon
softwar
use
evalu
ensembl
similar
ligand
candid
target
final
standard
ensembl
similar
cdk
dragon
integr
use
bayesian
network
rank
predict
target
cell
treat
indic
fix
glutaraldehyd
overnight
post
fix
osmium
tetroxid
h
room
temperatur
fixat
cell
embed
stain
uranyl
acetatelead
citrat
section
examin
transmiss
electron
microscop
japan
kv
cell
pm
plate
coverslip
h
treat
indic
method
coverslip
fix
paraformaldehyd
min
permeabil
triton
solarbio
beij
china
dissolv
pb
min
nucleoprotein
stain
coverslip
block
h
pb
contain
bovin
serum
albumin
bsa
triton
incub
primari
antibodi
display
supplementari
tabl
overnight
follow
secondari
antibodi
coverslip
counterstain
dapi
beyotim
shanghai
china
confoc
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
imag
captur
use
zeiss
confoc
microscop
jena
germani
planapo
chromat
oil
object
cell
cellswel
plate
plate
regular
medium
overnight
cultur
cell
wash
pb
incub
seri
concentr
lp
certain
treatment
h
subsequ
mtt
solut
mgml
ad
medium
total
volum
cell
incub
h
co
supernat
remov
dmso
ad
well
dissolv
produc
formazan
crystal
extinct
measur
nm
use
smartspec
spectrophotomet
biorad
hercul
ca
usa
mous
tissu
sampl
indic
time
point
pa
inject
blood
lung
spleen
collect
blood
homogen
cell
lung
spleen
tissu
serial
dilut
subsequ
diluent
ad
nutrient
agar
plate
cultur
h
imag
agar
plate
cfu
count
obtain
use
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
rpm
min
precipit
resuspend
mh
medium
serial
dilut
microlon
elisa
plate
coat
antibodi
vdr
antivdr
antibodi
cell
signal
technolog
boston
usa
overnight
follow
three
wash
pb
cell
lysat
contain
total
protein
includ
vdr
protein
ad
plate
incub
h
vdr
protein
captur
antivdr
antibodi
coat
plate
subsequ
plate
wash
three
time
v
selleck
houston
tx
usa
ad
incub
h
plate
wash
three
time
fluorophoreconjug
design
synthes
chongq
canbipharma
technolog
chongq
china
ad
incub
h
plate
wash
three
time
fluoresc
intens
observ
use
spectra
max
multifunct
enzym
marker
molecular
devic
usa
excit
wavelength
nm
emiss
wavelength
nm
fluorophor
dihydroartemisinin
name
de
dihydroartemisinin
name
ii
cell
sampl
cultur
supernat
collect
blood
sampl
serum
collect
mous
tissu
sampl
one
gram
lung
spleen
tissu
homogen
supernat
collect
cytokin
level
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
sampl
determin
use
appropri
elisa
kit
thermo
fisher
scientif
waltham
usa
accord
manufactur
protocol
level
nucleu
nucleoprotein
extract
detect
use
transam
kit
activ
motif
carlsbad
ca
usa
total
rna
extract
cell
tissu
use
magmax
total
rna
isol
kit
thermo
fisher
scientif
transcrib
cdna
use
prime
script
takara
dalian
china
use
respect
primer
display
supplementari
tabl
realtim
pcr
perform
fast
realtim
pcr
system
abi
realtim
pcr
system
appli
biosystem
darmstadt
germani
express
level
normal
reaction
perform
duplic
use
tli
rnaseh
plu
univers
pcr
master
mix
takara
rel
express
calcul
method
immunerel
procedur
use
compli
recommend
made
british
journal
pharmacolog
cell
protein
mice
spleen
extract
use
ripa
lysi
buffer
beyotim
shanghai
china
nuclear
cytoplasm
protein
isol
nucleoprotein
extract
kit
keygen
biotech
beij
china
protein
quantifi
use
bca
kit
beyotim
thirti
microgram
protein
sampl
separ
sdspage
transfer
polyvinyliden
difluorid
membran
membran
block
bsa
incub
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
chemiluminescencemark
imag
develop
use
enhanc
chemiluminesc
substrat
perkinelm
nrowalk
ct
usa
touch
imag
system
biorad
hercul
ca
usa
analyz
use
imag
lab
packag
biorad
cell
wash
cold
pb
crosslink
formaldehyd
stop
glycin
cell
sonic
chip
lysi
buffer
gener
bp
fragment
follow
overnight
incub
vdr
antibodi
abcam
cambridg
uk
obtain
dna
subject
semiquantit
quantit
pcr
analysi
tabl
use
amplifi
vdrbind
region
promot
gene
accord
previou
method
report
laboratori
wu
et
al
chip
assay
perform
use
pierc
agaros
chip
kit
follow
manufactur
instruct
thermo
pierc
rockford
il
usa
describ
bretin
et
al
nuclear
cytoplasm
protein
cell
isol
nucleoprotein
extract
kit
keygen
biotech
jiangsu
china
protein
mg
incub
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
antivdr
antibodi
cell
signal
technolog
overnight
immun
complex
collect
use
protein
ag
bead
subject
sdspage
western
blot
describ
coimmunoprecipit
coip
perform
accord
manual
protein
ag
magnet
bead
kit
thermo
fisher
scientif
data
statist
analys
compli
recommend
experiment
design
analysi
pharmacolog
curti
et
al
briefli
statist
analys
perform
use
graphpad
prism
graphpad
softwar
inc
ca
usa
data
express
mean
sd
analyz
use
oneway
anova
twotail
unpair
student
ttest
gehanbreslowwilcoxon
test
paramet
data
present
indic
p
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
result
result
clp
mice
show
treatment
decreas
mortal
clp
mice
challeng
pa
figur
suggest
could
protect
clpinduc
immunosuppress
mice
clp
mice
unchalleng
pa
level
extrem
low
serum
spleen
lung
howev
level
increas
significantli
astreat
clp
mice
figur
furthermor
cytokin
level
clp
mice
challeng
pa
also
much
lower
contrast
sham
mice
challeng
pa
demonstr
bacteri
challeng
could
induc
proinflammatori
cytokin
releas
sepsisinduc
immunosuppress
mice
importantli
treatment
significantli
augment
cytokin
level
figur
indic
could
increas
cytokin
level
sepsisinduc
immunosuppress
mice
subsequ
result
show
bacteri
load
obvious
increas
tissu
clp
mice
challeng
pa
compar
sham
mice
demonstr
clp
mice
lower
bacteri
clearanc
abil
howev
significantli
decreas
bacteri
load
figur
suggest
could
protect
sepsisinduc
immunosuppress
increas
proinflammatori
cytokin
releas
decreas
bacteri
load
base
concentrationeffect
relationship
lp
cytokin
product
figur
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
ngml
lp
fourhour
incub
follow
ngml
lp
determin
induc
lp
toler
phenotyp
toler
cell
figur
compar
cell
treat
ngml
lp
treatment
lp
cell
toler
cell
pretreat
ngml
lp
follow
ngml
lp
releas
much
less
figur
howev
exhibit
dosedepend
enhanc
releas
toler
cell
figur
result
show
bacteri
load
lp
toler
cell
increas
rel
lp
cell
h
pa
challeng
significantli
decreas
bacteria
load
toler
cell
figur
noteworthili
sinc
concentr
lp
ngml
use
experi
effect
cell
viabil
effect
relat
toxic
lp
cell
activ
figur
li
et
al
subsequ
human
monocyt
cell
line
deriv
macrophag
employ
confirm
whether
similar
effect
human
cell
ident
result
mrna
level
bacteri
clearanc
cell
deriv
macrophag
obtain
figur
g
result
consist
find
vivo
demonstr
might
revers
sepsisinduc
immunosuppress
enhanc
proinflammatori
cytokin
releas
bacteri
clearanc
macrophag
investig
molecular
mechan
interact
candid
predict
firstli
top
candid
figur
preliminarili
screen
use
rtpcr
among
signific
stabl
chang
observ
mrna
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
protein
level
vdr
remark
increas
toler
cell
decreas
figur
c
secondli
vdr
express
modifi
vdr
sirna
lentivir
vector
harbor
rnai
sequenc
vdr
transfect
cell
knock
vdr
express
vdrkd
cell
figur
result
show
knockdown
vdr
would
lead
loss
lp
toler
phenotyp
addit
make
differ
figur
lentivir
vector
harbor
vdr
gene
transfect
cell
overexpress
vdr
vdroe
cell
figur
result
show
aspromot
level
lp
toler
cell
abrog
overexpress
vdr
figur
find
indic
vdr
might
essenti
key
molecul
lp
toler
format
could
consid
interact
candid
thirdli
verifi
interact
vdr
indirect
competit
bind
assay
use
label
fluorophor
carri
figur
result
show
preincub
v
decreas
asrel
fluoresc
intens
significantli
figur
suggest
v
firstli
occupi
receptor
decreas
interact
vdr
lastli
base
v
natur
agonist
vdr
high
affin
haussler
jurutka
mizwicki
norman
effect
level
investig
presenc
absenc
v
valid
find
result
show
absenc
v
level
decreas
aspromot
releas
lp
toler
cell
howev
proincub
v
effect
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
aspromot
releas
elimin
figur
indic
antagon
v
result
strongli
indic
may
bind
receptor
even
similar
site
v
taken
togeth
aforement
find
demonstr
might
interact
vdr
subsequ
inhibit
biolog
function
vdr
therefor
consid
might
interact
vdr
antagonist
revers
lp
toler
state
vdr
nuclear
receptor
mediat
biolog
function
v
transloc
nucleu
regul
transcript
downstream
target
gene
via
bind
promotor
regul
v
mediat
regul
autophagi
antibacteri
effect
sun
therefor
nuclear
transloc
vdr
subsequ
effect
target
gene
investig
firstli
immunoblot
immunostain
result
show
vdr
protein
level
dramat
increas
nucleu
lp
toler
cell
compar
lp
cell
could
revers
figur
b
secondli
chip
assay
result
show
induc
bind
vdr
promot
analyz
semiquantit
pcr
rtpcr
lp
toler
cell
figur
togeth
data
show
effect
close
relat
transcript
regul
vdr
thirdli
immunoblot
result
indic
protein
level
lp
toler
cell
obvious
decreas
compar
lp
cell
increas
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
level
figur
suggest
vdr
neg
regul
transcript
lp
toler
cell
could
prevent
addit
result
demonstr
protein
level
lp
toler
cell
markedli
increas
vdrkd
group
compar
ctrlkd
group
effect
diminish
figur
howev
asincreas
level
lp
toler
cell
abrog
overexpress
vdr
figur
aforement
find
indic
inhibit
function
vdr
via
prevent
nuclear
transloc
vdr
thu
influenc
transcript
target
gene
autophagi
import
selfprotect
mechan
requir
bacteri
clearanc
inflamm
gutierrez
master
singh
taylor
colombo
deret
levin
mizushima
virgin
target
gene
vdr
regul
autophagi
link
vdr
autophagi
wu
sun
firstli
confirm
function
cell
treat
sirna
figur
result
show
level
lp
cell
decreas
promot
level
lp
toler
cell
elimin
sirna
infect
group
rel
neg
control
figur
suggest
associ
inflammatori
cytokin
releas
lp
toler
cell
effect
secondli
three
autophagi
inhibitor
target
bafilomycin
baf
block
autophagosom
lysosom
fusion
target
also
known
phosphatidylinositol
catalyt
subunit
type
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
use
cell
result
show
level
lp
cell
decreas
aspromot
level
lp
toler
cell
significantli
elimin
proincub
baf
figur
figur
furthermor
result
demonstr
markedli
declin
bacteria
load
lp
toler
cell
challeng
pa
effect
could
abrog
proincub
baf
figur
result
indic
potenti
correl
autophagi
effect
result
show
autophagi
contribut
effect
thirdli
influenc
autophagyrel
molecul
investig
herein
marker
convers
microtubul
associ
protein
light
chain
kda
kda
accumul
select
evalu
autophagi
activ
schaaf
keuler
vooij
rouschop
result
show
lp
treatment
increas
dosedepend
manner
figur
consist
result
lp
induc
proinflammatori
cytokin
releas
dosedepend
manner
figur
indic
lpsinduc
cytokin
releas
autophagi
involv
immunoblot
show
accumul
level
chang
time
lp
toler
cell
peak
h
figur
therefor
h
select
best
time
point
observ
lpsinduc
autophag
activ
fourthli
immunofluoresc
stain
transmiss
electron
microscopi
tem
immunoblot
result
reveal
autophagi
activ
remark
decreas
lp
toler
cell
rel
lp
cell
could
revers
treatment
figur
h
last
lp
treatment
result
indic
autophagi
declin
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
tightli
involv
lp
toler
phenotyp
treatment
potenti
autophag
activ
lastli
lp
toler
cell
level
markedli
increas
knock
vdr
compar
neg
control
addit
make
differ
figur
aspromot
level
lp
toler
cell
abrog
overexpress
vdr
figur
aforement
find
indic
effect
autophagydepend
vdr
vitro
import
nuclear
transcript
factor
regul
mani
proinflammatori
cytokin
transcript
target
gene
bonizzi
karin
vdr
physic
interact
mous
embryon
fibroblast
cell
intestin
cell
sun
et
al
wu
et
al
remain
unclear
function
relev
interact
lp
toler
macrophag
herein
coip
fluoresc
coloc
experi
perform
result
show
associ
level
cytoplasm
protein
signific
chang
medium
cell
lp
cell
lp
toler
cell
equal
amount
vdr
use
control
pulldown
vdr
significantli
decreas
treatment
figur
howev
effect
nucleu
protein
associ
treatment
equal
amount
vdr
use
control
pulldown
vdr
figur
result
suggest
might
bind
vdr
interrupt
interact
vdr
cytoplasm
impli
might
affect
activ
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
subsequ
immunostain
use
determin
whether
affect
intracellular
coloc
distribut
vdr
result
reveal
obviou
coloc
vdr
lp
toler
cell
significantli
inhibit
coloc
figur
moreov
nuclear
transloc
markedli
declin
lp
toler
cell
rel
lp
cell
revers
treatment
figur
result
indic
high
level
vdr
intens
interact
prevent
nuclear
transloc
noteworthili
inhibit
physic
interact
vdr
acceler
nuclear
transloc
confirm
nuclear
protein
level
investig
use
elisa
immunoblot
result
show
level
nucleu
obvious
reduc
lp
toler
cell
rel
lp
cell
revers
figur
lp
toler
cell
nuclear
level
increas
vdrkd
group
compar
neg
control
lead
loss
toler
phenotyp
figur
vdroe
cell
nucleoprotein
level
remark
suppress
compar
neg
control
treatment
made
differ
lp
toler
cell
figur
determin
whether
aspromot
proinflammatori
cytokin
releas
lp
toler
cell
relat
influenc
activ
express
modifi
figur
b
result
show
knockdown
would
lead
declin
proinflammatori
cytokin
releas
loss
effect
figur
simultan
overexpress
would
lead
loss
lp
toler
phenotyp
addit
make
differ
figur
aforement
find
indic
inhibit
physic
interact
vdr
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
lp
toler
macrophag
promot
nuclear
transloc
well
downstream
proinflammatori
cytokin
releas
correl
aforement
find
vitro
experi
mrna
protein
level
vdr
measur
clp
mice
result
show
level
vdr
mrna
protein
express
significantli
increas
pm
clp
mice
markedli
inhibit
figur
consist
vitro
result
vdrkd
clp
mice
vdr
express
knock
use
lentivir
vector
harbor
vdr
rnai
sequenc
vdrkd
figur
b
level
spleen
lung
significantli
increas
compar
neg
control
administr
made
differ
figur
suggest
vdr
overexpress
involv
sepsisinduc
immunosuppress
formul
knock
vdr
would
lead
loss
immunosuppress
phenotyp
addit
immunoblot
result
show
autophagyassoci
protein
spleen
clp
mice
increas
compar
neg
control
made
differ
figur
taken
togeth
vivo
vitro
result
indic
vdr
play
import
role
sepsisinduc
immunosuppress
effect
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
herein
result
demonstr
interact
vdr
revers
sepsisinduc
immunosuppress
autophagi
depend
way
togeth
previou
result
kuang
et
al
li
et
al
discov
inhibit
proinflammatori
cytokin
releas
hyperinflamm
stage
also
enhanc
proinflammatori
cytokin
releas
bacteri
clearanc
macrophag
revers
sepsisinduc
immunosuppress
vivo
vitro
demonstr
exhibit
immunoregul
effect
sepsi
treatment
report
previous
sepsi
lifethreaten
condit
caus
dysregul
host
respons
infect
singer
et
al
last
decad
revers
sepsisinduc
immunosuppress
becom
focu
sepsi
research
instead
target
cytokin
storm
cohen
hotchkiss
monneret
payen
kox
volk
kox
volk
prucha
zazula
russwurm
howev
drug
current
clinic
trial
antiprogram
cell
death
antibodi
probabl
immunosuppress
stage
sepsi
hotchkiss
monneret
payen
prucha
zazula
russwurm
clinic
efficaci
yet
proven
clinic
investig
consist
shown
close
correl
vitamin
defici
serum
excess
mortal
morbid
suggest
vitamin
defici
tightli
relat
sepsi
dickerson
et
al
conflict
result
variou
studi
whether
vitamin
supplement
improv
outcom
patient
sepsi
kearn
alvarez
seidel
tangpricha
putzu
et
al
clinic
investig
outcom
sepsi
patient
accept
vitamin
supplement
requir
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
futur
consid
extens
biolog
effect
vitamin
well
role
mainten
homeostasi
organ
necessari
maintain
physiolog
concentr
vitamin
base
result
consid
low
level
vitamin
might
lead
insuffici
antiinflamm
respons
human
bodi
excess
vitamin
might
induc
high
level
vdr
express
howev
excess
overexpress
vdr
might
lead
decreas
immun
function
thu
vitamin
supplement
necessari
diet
excess
intak
vitamin
might
benefit
therefor
consid
ideal
immunotherapi
sepsi
exert
antiinflammatori
effect
cytokin
storm
stage
also
increas
resist
infect
immunosuppress
stage
therapeut
effect
cytokin
storm
stage
sepsi
mechan
prove
previou
studi
kuang
et
al
li
et
al
li
et
al
herein
reveal
possess
therapeut
effect
sepsisinduc
immunosuppress
vivo
vitro
vdr
belong
nuclear
famili
receptor
activ
vdr
bind
preferenti
heterodim
retinoid
x
receptor
rxr
hexamer
repeat
vitamin
respons
element
vdre
promot
region
target
gene
haussler
et
al
orlov
rochel
mora
klaholz
nuclear
receptor
nuclear
transloc
rxrvdr
heterodim
function
recruit
addit
cofactor
play
essenti
role
transcript
haussler
et
al
herein
vdr
firstli
predict
interact
molecul
candid
tcmsp
identifi
use
pcr
wb
moreov
found
vdr
highli
express
nuclear
transloc
vdr
strikingli
increas
lp
toler
cell
mimic
immunosuppress
stage
sepsi
compar
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
lp
cell
mimic
cytokin
storm
stage
treatment
could
markedli
inhibit
high
express
nuclear
transloc
vdr
furthermor
interact
vdr
confirm
bind
assay
establish
lab
result
demonstr
might
interact
vdr
affect
activ
lead
declin
vdr
nuclear
transloc
thu
effect
investig
presenc
absenc
v
natur
ligand
vdr
result
show
effect
elimin
proincub
v
indic
antagon
v
result
strikingli
suggest
might
bind
receptor
even
similar
site
v
although
antiinflamm
immunosuppress
effect
v
report
tightli
relat
function
vdr
alroy
tower
freedman
joshi
et
al
lemir
adam
kermaniarab
bakk
sakai
jordan
studi
directli
address
role
vdr
sepsisinduc
immunosuppress
base
result
specul
excess
high
level
vdr
immunosuppress
stage
sepsi
might
relat
decreas
inflammatori
respons
could
increas
surviv
rate
sepsi
anim
via
inhibit
high
express
vdr
autophagi
fundament
cellular
process
involv
defens
infect
elimin
intracellular
pathogen
regul
inflamm
casanova
autophagi
consid
new
target
sepsi
treatment
ren
zhang
wu
yao
herein
combin
previou
studi
kuang
et
al
consid
autophagi
enhanc
earli
sepsi
stage
cytokin
storm
stage
suppress
later
sepsi
stage
immunosuppress
stage
result
also
show
could
enhanc
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
autophagi
lp
toler
cell
elimin
bacteria
inhibit
autophagi
use
sirna
autophagi
inhibitor
could
lead
loss
effect
bacteria
clearanc
cytokin
releas
suggest
autophagi
play
crucial
part
effect
vdr
report
involv
immunoregul
resist
infect
via
regul
autophagi
baek
takiishi
korf
gyseman
mathieu
goi
ferreira
olenski
seguro
vdr
transcript
regul
target
gene
import
autophagyrel
protein
molecul
vdr
reduc
also
reduc
associ
abnorm
paneth
cell
develop
chronic
state
mucos
inflamm
sun
howev
find
show
high
bind
vdr
promotor
lead
low
protein
level
lp
toler
cell
demonstr
vdr
neg
regul
transcript
lp
toler
cell
base
result
show
could
inhibit
vdr
express
upregul
transcript
increas
autophagi
activ
consid
discrep
transcript
regul
vdr
might
due
differ
inflamm
immun
statu
howev
mechan
need
investig
futur
vital
transcript
factor
signal
pathway
link
pathogen
signal
cellular
danger
signal
thu
organ
cellular
resist
invad
pathogen
network
hub
respons
complex
biolog
signal
albensi
mattson
kaltschmidt
kaltschmidt
report
physic
interact
vdr
mous
embryon
fibroblast
cell
intestin
cell
sun
et
al
wu
et
al
previou
studi
shown
could
significantli
inhibit
lpsinduc
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
activ
macrophag
lead
reduc
releas
proinflammatori
cytokin
kuang
et
al
li
et
al
therebi
play
antiinflammatori
role
herein
focus
function
sepsi
immunosuppress
stage
discov
neg
regul
vdr
due
physic
interact
macrophag
importantli
prevent
interact
vdr
lpstoler
cell
lead
mark
increas
nuclear
transloc
express
downstream
target
gene
furthermor
found
decreas
bind
vdr
promot
region
lead
declin
nuclear
transloc
vdr
decreas
neg
transcript
lastli
enhanc
autophagi
activ
bind
vdr
furthermor
knock
vdr
express
revers
autophagi
relat
protein
level
immunosuppress
stage
express
vdr
result
failur
aspromot
autophagi
relat
protein
level
thu
conclud
interact
vdr
revers
immunosuppress
stage
autophagi
involv
taken
togeth
think
interact
vdr
therebi
inhibit
nuclear
transloc
vdr
also
inhibit
physic
interact
vdr
lp
toler
macrophag
promot
nuclear
transloc
enhanc
autophagi
activ
transcript
target
gene
proinflammatori
cytokin
know
vdr
receptor
recogn
bind
v
v
control
vdr
achiev
antisepsi
effect
although
clinic
investig
shown
close
correl
vitamin
defici
serum
excess
morbid
mortal
sepsi
suggest
vitamin
defici
close
relat
sepsi
dickerson
et
al
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
remain
conflict
vitamin
supplement
improv
outcom
patient
sepsi
kearn
alvarez
seidel
tangpricha
putzu
et
al
consid
extens
biolog
effect
vitamin
well
role
mainten
homeostasi
organ
necessari
import
maintain
physiolog
concentr
vitamin
noteworthi
excess
vitamin
supplement
may
harm
rather
benefici
base
result
excess
vitamin
might
induc
high
level
vdr
express
might
lead
decreas
immun
function
till
outcom
therapeut
regim
aim
singl
stage
sepsi
disappoint
even
wors
might
due
treatment
time
window
import
therapeut
regimen
sepsi
difficult
grasp
give
antiinflammatori
drug
hypoinflammatori
stage
proinflammatori
therapi
hyperinflammatori
stage
lead
failur
even
increas
mortal
clinic
hotchkiss
monneret
payen
rudick
cornel
agraw
therefor
consid
immunoregul
might
ideal
drug
sepsi
without
limit
treatment
time
window
result
demonstr
might
immunoregul
hyperand
hypoinflammatori
stage
sepsi
base
previou
current
result
mechan
exert
proinflammatori
effect
immunosuppress
stage
contrast
antiinflammatori
effect
cytokin
storm
stage
present
result
outlin
mechan
effect
two
way
present
figur
interact
vdr
prevent
nuclear
transloc
vdr
decreas
neg
regul
autophagi
relat
target
gene
increas
autophagi
activ
addit
interact
vdr
prevent
interact
vdr
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
increas
nuclear
transloc
augment
transcript
target
gene
proinflammatori
cytokin
two
way
lead
increas
bacteria
clearanc
proinflammatori
cytokin
releas
macrophag
although
monocytesmacrophag
system
play
vital
role
sepsi
acquir
immun
system
equal
import
effect
b
cell
function
remain
investig
futur
howev
given
therapeut
effect
clp
anim
model
firmli
believ
improv
function
b
cell
vdr
interact
molecul
whether
vdr
drug
target
remain
studi
futur
overal
find
provid
evid
interact
vdr
revers
sepsisinduc
immunosuppress
autophagi
depend
way
highlight
novel
approach
sepsi
treatment
drug
repurpos
futur
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
author
contribut
ss
jw
xl
perform
studi
guidanc
h
z
ss
collect
analyz
data
h
z
ss
wrote
manuscript
xl
pl
contribut
establish
mous
model
ss
lx
perform
bacteria
clearanc
experi
ss
jw
respons
molecular
biolog
experi
yw
xc
complet
bioinformat
analysi
hz
jz
sl
ss
contribut
discuss
hz
jz
sl
revis
manuscript
h
z
guarantor
work
full
access
data
take
full
respons
integr
data
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
figur
figur
action
mechan
flow
chart
interact
vdr
prevent
nuclear
transloc
vdr
decreas
neg
regul
autophagi
relat
target
gene
increas
autophagi
activ
addit
interact
vdr
prevent
interact
vdr
increas
nuclear
transloc
augment
transcript
target
gene
proinflammatori
cytokin
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
